Denise Garner - Sep 21, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
SVP - Chief Innovation Officer
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Sep 21, 2021
Transactions value $
$121,274
Form type
4
Date filed
9/23/2021, 07:21 PM
Previous filing
Aug 23, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock +Grant/Award $129,870 +793 +7.73% $163.77 11,047 Sep 21, 2021 Direct F1
transaction CLX Common Stock -Tax liability -$8,596 -53 -0.48% $162.19 10,996 Sep 22, 2021 Direct F2, F3
holding CLX Common Stock 2,178 Sep 21, 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Stock Option (Right to Buy) +Grant/Award $0 +5,836 $0.00 5,836 Sep 21, 2021 Common Stock 5,836 $163.77 Direct F4

Explanation of Responses:

Id Content
F1 The Restricted Stock Units will vest in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025.
F2 Withholding of shares by the Company to satisfy tax obligations applicable to vesting of restricted stock.
F3 Includes 2 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
F4 Option vests in 4 equal installments on each of October 5 of 2022, 2023, 2024 and 2025.